Lornoxicam (Standard)
Lornoxicam (Standard) is the analytical standard of Lornoxicam. This product is intended for research and analytical applications. Lornoxicam (Chlortenoxicam) is a highly active COX-1 and COX-2 inhibitor with IC50 of 5 nM and 8 nM respectively. It is a new non-steroidal anti-inflammatory compound.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté : 98%
- CAS No.: 70374-39-9
- Formule: C13H10ClN3O4S2
- Masse moléculaire:371.82
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- Pureté et documentation
-
Help & FAQs
-
HY-B0367
LornoxicamCOX Inhibitor -
HY-B0574
Mefenamic acidCOX Inhibitor -
HY-14398
CelecoxibCOX-2inhibitor -
HY-B0138
Ketorolac tromethamine saltCOX Inhibitor -
HY-10582
FlurbiprofenCOX Inhibitor -
HY-B0261
MeloxicamCOX Inhibitor -
HY-78131
IbuprofenCOX-1 Inhibitor -
HY-10582R
Flurbiprofen (Standard)COX Inhibitor -
HY-B0253
PiroxicamCOX Inhibitor -
HY-B0083
LeflunomideDHODH Inhibitor -
HY-N0262
CordycepinBacterial Inhibitor -
HY-15036
DiclofenacCOX Inhibitor
Product Information
Information
Application
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
CAS No. 70374-39-9
-
Masse moléculaire 371.82
-
Formule C13H10ClN3O4S2
-
SMILES
O=C(C1=C(O)C2=C(C=C(Cl)S2)S(N1C)(=O)=O)NC3=NC=CC=C3
-
Synonyms
Chlortenoxicam (Standard); Ro 13-9297 (Standard)
-
Structure Classification
-
Initial Source
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
[1]. Spyra S, et al. COX-2-selective inhibitors celecoxib and deracoxib modulate transient receptor potential vanilloid 3 channels. Br J Pharmacol. 2017 Aug;174(16):2696-2705. [Content Brief]
[2]. Rose, P. and C. Steinhauser, Comparison of Lornoxicam and Rofecoxib in Patients with Activated Osteoarthritis (COLOR Study). Clin Drug Investig, 2004. 24(4): p. 227-36. [Content Brief]
[3]. Bianchi, M. and A.E. Panerai, Effects of lornoxicam, piroxicam, and meloxicam in a model of thermal hindpaw hyperalgesia induced by formalin injection in rat tail. Pharmacol Res, 2002. 45(2): p. 101-5. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Lornoxicam (Standard) Related Classifications
HY-B0367R Related Classifications
Powered by Bioz